Literature DB >> 7700262

Stereoselective esterase activity of human serum albumin toward ketoprofen glucuronide.

N Dubois-Presle1, F Lapicque, M H Maurice, S Fournel-Gigleux, J Magdalou, M Abiteboul, G Siest, P Netter.   

Abstract

Many carboxylic acid-containing drugs undergo conjugation with D-glucuronic acid in humans, leading to the formation of acyl glucuronides, which are excreted into urine. However, these metabolites can be hydrolyzed back to the parent aglycon; this reaction can be accelerated by human serum albumin (HSA). Although this phenomenon of interaction between the acyl glucuronide and HSA has been described for various drugs, the kinetics of the protein have not been characterized. The aim of this study was to investigate the HSA-mediated mechanism involved in the in vitro hydrolysis by albumin of the acyl glucuronides of (R)- and (S)-ketoprofen (a nonsteroidal anti-inflammatory drug), as model compounds. The conjugates of both ketoprofen enantiomers were incubated, separately or together, with increasing concentrations of albumin (14.5-145 microM) at pH 7.4 and 37 degrees. The reaction followed Michaelis-Menten kinetics and was stereoselective; the (R)-ketoprofen glucuronide was a better substrate than the S-conjugate. To identify the HSA domain involved in the hydrolysis reaction, specific probes of HSA binding sites were used as potential inhibitors. These probes, added at an equimolar probe/glucuronide ratio (145 microM), slightly decreased the hydrolysis (by up to 30%). They affected the reversible binding of (R)-ketoprofen glucuronide to HSA, as shown by CD studies. Because iodoacetic acid did not modify the single free cysteine residue on HSA, this amino acid residue cannot be the reactive one. In addition, the chemical modification of a single tyrosine residue (probably Tyr-411) on HSA by diisopropyl fluorophosphate significantly but weakly affected the hydrolysis of (R)-ketoprofen glucuronide, suggesting that this residue also is not involved in the catalysis. In contrast, the R-conjugate was not bound to modified albumin, as revealed in CD experiments. These results support the existence of distinct sites on HSA for reversible binding and hydrolysis of (R)-ketoprofen glucuronide.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7700262

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  8 in total

1.  Interaction of polypyridyl Cr(III) complexes with bovine serum albumin.

Authors:  Pablo F Garcia; Consuelo Coronel Arrechea; Alejandra Velo; Julieta Riva; Lidia M Yudi; Gerardo A Argüello
Journal:  Eur Biophys J       Date:  2020-01-11       Impact factor: 1.733

Review 2.  Preclinical and clinical development of dexketoprofen.

Authors:  D Mauleón; R Artigas; M L García; G Carganico
Journal:  Drugs       Date:  1996       Impact factor: 9.546

Review 3.  Overview of extracellular microvesicles in drug metabolism.

Authors:  Javier Conde-Vancells; Esperanza Gonzalez; Shelly C Lu; Jose M Mato; Juan M Falcon-Perez
Journal:  Expert Opin Drug Metab Toxicol       Date:  2010-05       Impact factor: 4.481

Review 4.  Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions.

Authors:  R J Bertz; G R Granneman
Journal:  Clin Pharmacokinet       Date:  1997-03       Impact factor: 6.447

5.  Pseudo-esterase activity of human albumin: slow turnover on tyrosine 411 and stable acetylation of 82 residues including 59 lysines.

Authors:  Oksana Lockridge; Weihua Xue; Andrea Gaydess; Hasmik Grigoryan; Shi-Jian Ding; Lawrence M Schopfer; Steven H Hinrichs; Patrick Masson
Journal:  J Biol Chem       Date:  2008-06-24       Impact factor: 5.157

6.  Serum Albumin Binding and Esterase Activity: Mechanistic Interactions with Organophosphates.

Authors:  Nikolay V Goncharov; Daria A Belinskaia; Vladimir I Shmurak; Maxim A Terpilowski; Richard O Jenkins; Pavel V Avdonin
Journal:  Molecules       Date:  2017-07-18       Impact factor: 4.411

7.  Stereoselective Covalent Adduct Formation of Acyl Glucuronide Metabolite of Nonsteroidal Anti-Inflammatory Drugs with UDP-Glucuronosyltransferase.

Authors:  Atsushi Kawase; Rio Yamashita; Tsubasa Yoshizato; Mashiro Yoshikawa; Hiroaki Shimada; Masahiro Iwaki
Journal:  Int J Mol Sci       Date:  2022-04-25       Impact factor: 5.923

8.  A molecular dynamics approach to ligand-receptor interaction in the aspirin-human serum albumin complex.

Authors:  H Ariel Alvarez; Andrés N McCarthy; J Raúl Grigera
Journal:  J Biophys       Date:  2012-11-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.